John Brady (Wicklow, Sinn Fein)
Link to this: Individually | In context | Oireachtas source

31. To ask the Minister for Health the number of drugs where, following the National Centre for Pharmacoeconomics, NCPE, assessment of the manufacturer's economic dossier on the cost effectiveness of a drug, including details on all relevant costs and relevant cost offsets including hospitalisation, disease management costs, intravenous antibiotics, adverse events and any additional costs arising in patients not taking a drug, the NCPE found a drug not to be cost effective; if he will provide this information for each of the past five years with a breakdown of whether additional price reductions were successfully negotiated and agreed upon; and if he will make a statement on the matter. [37860/16]

Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

As this is a service matter it has been referred to the HSE for reply to the Deputy.